T0	Outcomes 844 899	12-month changes in spine and hip bone mineral density.
T1	Outcomes 928 1129	changes in markers of bone resorption (urine N-telopeptide cross-linked collagen type I) and formation (osteocalcin, N-terminal propeptide of type I procollagen, and bone-specific alkaline phosphatase)
T2	Outcomes 1156 1176	bone mineral density
T3	Outcomes 1389 1431	N-telopeptide cross-linked collagen type I
T4	Outcomes 1679 1688	tolerated
T5	Outcomes 1698 1712	retention rate